Pfizer Asks For Quick Review In Norvasc Feud

Law360, New York (June 4, 2007, 12:00 AM EDT) -- Pfizer Inc. has asked the nation's highest court to expedite its bid for a writ of certiorari in its patent feud with Apotex Inc. over blockbuster blood pressure drug Norvasc, arguing that a lower court's recent refusal to rehear the case could have “potentially wide-reaching consequences for the entire pharmaceutical research industry.”

Pfizer on May 30 filed with the U.S. Supreme Court a motion to expedite consideration of its petition for a writ of certiorari, which was submitted to the court on the same day....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.